-
Something wrong with this record ?
Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia
Z. Vrzalová, Z. Hrubá, ES. Hrabincová, S. Vrábelová, F. Votava, S. Koloušková, L. Fajkusová,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS9981
MZ0
CEP Register
- MeSH
- Adrenal Hyperplasia, Congenital genetics MeSH
- Humans MeSH
- DNA Mutational Analysis MeSH
- Mutant Chimeric Proteins genetics MeSH
- Pseudogenes genetics MeSH
- Recombination, Genetic MeSH
- Steroid 21-Hydroxylase genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czechoslovakia MeSH
Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders caused by an enzymatic deficiency which impairs the biosynthesis of cortisol and, in the majority of severe cases, also the biosynthesis of aldosterone. Approximately 95% of all CAH cases are caused by mutations in the steroid 21-hydroxylase gene (CYP21A2). The CYP21A2 gene and its inactive pseudogene (CYP21A1P) are located within the HLA class III region of the major histocompatibility complex (MHC) locus on chromosome 6p21.3. In this study, we describe chimeric CYP21A1P/CYP21A2 genes detected in our patients with 21-hydroxylase deficiency (21OHD). Chimeric CYP21A1P/CYP21A2 genes were present in 171 out of 508 mutated CYP21A2 alleles (33.8%). We detected four types of chimeric CYP21A1P/CYP21A2 genes: three of them have been described previously as CH-1, CH-3, CH-4, and one type is novel. The novel chimeric gene, termed CH-7, was detected in 21.4% of the mutant alleles. Possible causes of CYP21A1P/CYP21A2 formation are associated with 1) high recombination rate in the MHC locus, 2) high recombination rate between highly homologous genes and pseudogenes in the CYP21 gene area, and 3) the existence of chi-like sequences and repetitive minisatellite consensus sequences in CYP21A2 and CYP21A1P which play a role in promoting genetic recombination.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027951
- 003
- CZ-PrNML
- 005
- 20141111122457.0
- 007
- ta
- 008
- 120817e20101021ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejmg.2010.10.005 $2 doi
- 035 __
- $a (PubMed)20970527
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vrzalová, Zuzana $u University Hospital Brno, Centre of Molecular Biology and Gene Therapy, Czech Republic.
- 245 10
- $a Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia / $c Z. Vrzalová, Z. Hrubá, ES. Hrabincová, S. Vrábelová, F. Votava, S. Koloušková, L. Fajkusová,
- 520 9_
- $a Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders caused by an enzymatic deficiency which impairs the biosynthesis of cortisol and, in the majority of severe cases, also the biosynthesis of aldosterone. Approximately 95% of all CAH cases are caused by mutations in the steroid 21-hydroxylase gene (CYP21A2). The CYP21A2 gene and its inactive pseudogene (CYP21A1P) are located within the HLA class III region of the major histocompatibility complex (MHC) locus on chromosome 6p21.3. In this study, we describe chimeric CYP21A1P/CYP21A2 genes detected in our patients with 21-hydroxylase deficiency (21OHD). Chimeric CYP21A1P/CYP21A2 genes were present in 171 out of 508 mutated CYP21A2 alleles (33.8%). We detected four types of chimeric CYP21A1P/CYP21A2 genes: three of them have been described previously as CH-1, CH-3, CH-4, and one type is novel. The novel chimeric gene, termed CH-7, was detected in 21.4% of the mutant alleles. Possible causes of CYP21A1P/CYP21A2 formation are associated with 1) high recombination rate in the MHC locus, 2) high recombination rate between highly homologous genes and pseudogenes in the CYP21 gene area, and 3) the existence of chi-like sequences and repetitive minisatellite consensus sequences in CYP21A2 and CYP21A1P which play a role in promoting genetic recombination.
- 650 _2
- $a kongenitální adrenální hyperplazie $x genetika $7 D000312
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutantní chimérické proteiny $x genetika $7 D050506
- 650 _2
- $a pseudogeny $x genetika $7 D011544
- 650 _2
- $a rekombinace genetická $7 D011995
- 650 _2
- $a steroid-21-hydroxylasa $x genetika $7 D013255
- 651 _2
- $a Československo $7 D003604
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hrubá, Zuzana
- 700 1_
- $a Hrabincová, Eva Sťahlová
- 700 1_
- $a Vrábelová, Slávka
- 700 1_
- $a Votava, Felix
- 700 1_
- $a Koloušková, Stanislava
- 700 1_
- $a Fajkusová, Lenka
- 773 0_
- $w MED00166495 $t European journal of medical genetics $x 1878-0849 $g Roč. 54, č. 2 (20101021), s. 112-117
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20970527 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20141111122510 $b ABA008
- 999 __
- $a ok $b bmc $g 949993 $s 785297
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 54 $c 2 $d 112-117 $e 20101021 $i 1878-0849 $m European journal of medical genetics $n Eur. J. med. genet. $x MED00166495
- GRA __
- $a NS9981 $p MZ0
- LZP __
- $a Pubmed-20120817/11/03